Chronic kidney disease risk factors in development of renal dysfunction in chronic heart failure patients
- Authors: Kirshina NS1, Pimenov LT1
-
Affiliations:
- Issue: No 3 (2011)
- Pages: 61-64
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245980
- ID: 245980
Cite item
Full Text
Abstract
Aim. Determination of prevalence of chronic kidney disease (CKD) and it's risk factors in patients with chronic heart failure (CHF).
Methods. 167 patients (21 male and 146 female, mean age 60,9±11,4 years) with CHF I-IV (NYHA) were included into the study. Risk factors - body mass index (BMI), serum total cholesterol (TC), low density (LDL-C) and high density lipoprotein (HDL-C) cholesterol , triglycerides (TG), uric acid and creatinine level - were determined. Blood pressure (BP) and heart rate (HR) were determined. Glomerular filtration rate (GFR) was assessed by Cockroft-Gault formula.
Results. According to age increase CHF becomes more severe and is associated with GFR fall with simultaneous creatininemia increase. Increase of CHF severity is accompanied with BMI and GFR decrease, as well as with the increase in HR. Higher mean BP is associated with higher creatininemia, low diastolic BP - with decrease in GFR. Rise in serum uric acid level correlates with dislipidemia.
Conclusion. In CHF patients CKD development and progression is associated with risk factor dynamics.
Methods. 167 patients (21 male and 146 female, mean age 60,9±11,4 years) with CHF I-IV (NYHA) were included into the study. Risk factors - body mass index (BMI), serum total cholesterol (TC), low density (LDL-C) and high density lipoprotein (HDL-C) cholesterol , triglycerides (TG), uric acid and creatinine level - were determined. Blood pressure (BP) and heart rate (HR) were determined. Glomerular filtration rate (GFR) was assessed by Cockroft-Gault formula.
Results. According to age increase CHF becomes more severe and is associated with GFR fall with simultaneous creatininemia increase. Increase of CHF severity is accompanied with BMI and GFR decrease, as well as with the increase in HR. Higher mean BP is associated with higher creatininemia, low diastolic BP - with decrease in GFR. Rise in serum uric acid level correlates with dislipidemia.
Conclusion. In CHF patients CKD development and progression is associated with risk factor dynamics.
References
- Резник Е.В., Гендлин Г.Е., Сторожаков Г.И., Волынкина В.М. Изменения функции почек у больных ХСН. Сердечная Недостаточность 2007; 8(2): 89-94.
- Резник Е.В., Гендлин Г.Е., Сторожаков Г.И., Волынкина В.М. Почечная гемодинамика у больных хронической сердечной недостаточностью. Сердечная Недостаточность 2007; 8(3): 118-123.
- Мухин Н.А. Снижение скорости клубочковой фильтрации - общепопуляционный маркер неблагоприятного прогноза. Тер. архив 2007; 6: 5-10.
- Sarnak M.J., Cornado B.E., Greene T. et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin. Nephrol. 2002; 57: 327-335.
- Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Рекомендации научно - исследовательского института нефрологии Санкт - Петербургского государственного медицинского университета им. академ. И.П. Павлова: определение, классификация, диагностика и основные направления профилактики хронической болезни почек у взрослых. Нефрология 2008; 12(2): 75-93.
- Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардио - ренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9(3): 7-15.
- Мухин Н.А., Балкаров И.М., Моисеев С.В. и др. Хронические прогрессирующие нефропатии и образ жизни современного человека. Тер. архив 2004; 9: 5-9.
- Арутюнов А.Г., Костюкевич О.И., Звонова Е.В., Топильская Н.В. Исследование распространенности и клинической значимости гипотрофии у терапевтических больных. Сердечная Недостаточность 2007; 8(3): 144-148.
- Шилов Е.М., Фомин В.В., Швецов М.Ю. Хроническая болезнь почек. Тер. архив 2007; 6: 75-78.
- Сагинова Е.А., Федорова Е.А., Фомин В.В. и др. Формирование поражения почек у больных ожирением. Тер. архив 2006; 5: 36-41
- De Jong P.E., Verhave J.C., Pinto - Siestma S.J. et al. Obesity and target organ damage: the kidney. Int. J. Obes. Relat. Metab. Disord. 2002; 26(4): 21- 24.
- Borchard U. Роль симпатической нервной системы в развитии сердечно - сосудистых заболеваний. Обзоры клинической фармакологии 2006; 1: 2-7.
- Rump L.C. Роль симпатической нервной системы в развитии хронической почечной недостаточности. Обзоры клинической фармакологии 2006; 1: 8-15
- Blankestijn P.J. Sympathetic hyperactivity in chronic kidney disease. Nephrol. Dial. Transplant. 2004; 19(6): 1354-1357
- Koomans H.A., Blankestijn P.J., Joles J.A. Sympathetic hyperactivity in chronic renal failure: a wake - up call. J. Am. Soc. Nephrol. 2004; 15(3): 524-537.
Supplementary files
